Literature DB >> 9431962

Sporadic emergence of Klebsiella pneumoniae strains resistant to cefepime and cefpirome in Greek hospitals.

L S Tzouvelekis1, E Tzelepi, E Prinarakis, M Gazouli, A Katrahoura, P Giakkoupi, O Paniara, N J Legakis.   

Abstract

The sporadic emergence of Klebsiella pneumoniae strains resistant to cefepime and cefpirome was observed in Greek hospitals during 1996. Examination of six epidemiologically distinct strains and clones selected in vitro provided indications that resistance is due to the cooperation of decreased outer membrane permeability and hydrolysis of the cephalosporins by SHV-5 beta-lactamase, which was produced in large amounts.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9431962      PMCID： PMC124849     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  ERIC sequences: a novel family of repetitive elements in the genomes of Escherichia coli, Salmonella typhimurium and other enterobacteria.

Authors:  C S Hulton; C F Higgins; P M Sharp
Journal:  Mol Microbiol       Date:  1991-04       Impact factor: 3.501

2.  Prevalence of a transferable SHV-5 type beta-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece.

Authors:  A C Vatopoulos; A Philippon; L S Tzouvelekis; Z Komninou; N J Legakis
Journal:  J Antimicrob Chemother       Date:  1990-11       Impact factor: 5.790

3.  In vitro activity of cefpirome against selected clinical enterobacterial isolates with beta-lactamase-mediated resistance.

Authors:  L S Tzouvelekis; E Tzelepi; A F Mentis; N J Legakis
Journal:  Infection       Date:  1995 Nov-Dec       Impact factor: 3.553

4.  Efficacy of different beta-lactams against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model.

Authors:  L B Rice; J D Yao; K Klimm; G M Eliopoulos; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

Review 5.  More extended-spectrum beta-lactamases.

Authors:  G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

6.  Outer membrane permeability and beta-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents.

Authors:  H Nikaido; W Liu; E Y Rosenberg
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

Review 7.  beta-Lactamases in laboratory and clinical resistance.

Authors:  D M Livermore
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

8.  Molecular epidemiology of plasmid spread among extended broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in a pediatric hospital.

Authors:  E H Bingen; P Desjardins; G Arlet; F Bourgeois; P Mariani-Kurkdjian; N Y Lambert-Zechovsky; E Denamur; A Philippon; J Elion
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

9.  Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a geriatric hospital.

Authors:  A Gouby; C Neuwirth; G Bourg; N Bouziges; M J Carles-Nurit; E Despaux; M Ramuz
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

10.  Klebsiella pneumoniae infections in Greek hospitals. Dissemination of plasmids encoding an SHV-5 type beta-lactamase.

Authors:  N J Legakis; L S Tzouvelekis; G Hatzoudis; E Tzelepi; A Gourkou; T L Pitt; A C Vatopoulos
Journal:  J Hosp Infect       Date:  1995-11       Impact factor: 3.926
View more
  6 in total

1.  Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit in the high-prevalence area of Athens, Greece.

Authors:  E Lebessi; H Dellagrammaticas; P T Tassios; L S Tzouvelekis; S Ioannidou; M Foustoukou; N J Legakis
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  First report of extended-spectrum-beta-lactamase-producing Salmonella enterica isolates in Ireland.

Authors:  Dearbhaile Morris; Mary Whelan; Geraldine Corbett-Feeney; Martin Cormican; Peter Hawkey; Xu Li; Geraldine Doran
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

3.  Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae.

Authors:  L Martínez-Martínez; A Pascual; S Hernández-Allés; D Alvarez-Díaz; A I Suárez; J Tran; V J Benedí; G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

4.  Energy-dependent accumulation of norfloxacin and porin expression in clinical isolates of Klebsiella pneumoniae and relationship to extended-spectrum beta-lactamase production.

Authors:  Luis Martínez-Martínez; Alvaro Pascual; María del Carmen Conejo; Isabel García; Providencia Joyanes; Antonio Doménech-Sánchez; Vicente Javier Benedí
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

5.  Cefepime MIC as a predictor of the extended-spectrum beta-lactamase type in Klebsiella pneumoniae, Taiwan.

Authors:  Wen Liang Yu; Michael A Pfaller; Patricia L Winokur; Ronald N Jones
Journal:  Emerg Infect Dis       Date:  2002-05       Impact factor: 6.883

6.  Use of molecular typing to investigate bacterial translocation from the intestinal tract of chlorpyrifos-exposed rats.

Authors:  Claire Joly Condette; Bertin Elion Dzon; Farida Hamdad; Maurice Biendo; Véronique Bach; Hafida Khorsi-Cauet
Journal:  Gut Pathog       Date:  2016-11-05       Impact factor: 4.181
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.